ClinicalTrials.Veeva
Menu

Find clinical trials for Adenocarcinoma in Budapest, Budapest

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Non-Small-Cell Lung Carcinoma
Pancreatic Cancer
Colorectal Cancer
Stomach Cancer
Esophageal Cancer
Cancer
Prostatic Cancer

Adenocarcinoma trials near Budapest, Budapest, HUN:

Trastuzumab Deruxtecan for Subjects With HER2-Positive Gastric Cancer or Gastro-Esophageal Junction Adenocarcinoma After Progression on or After a Trastuzumab-Containing Regimen (DESTINY-Gastric04)

with HER2-positive gastric or gastro-esophageal junction (GEJ) adenocarcinoma who have progressed on or after a trastuzumab-containing regim...

Active, not recruiting
Gastric Cancer, Adenocarcinoma
Gastroesophageal Junction Adenocarcinoma
Drug: Ramucirumab
Drug: Paclitaxel

Phase 3

Daiichi Sankyo
Daiichi Sankyo

Budapest, Hungary and 155 other locations

A Clinical Trial of a New Combination Treatment, Domvanalimab and Zimberelimab, Plus Chemotherapy, for People With an Upper Gastrointestinal Tract Cancer That Cannot be Removed With Surgery That Has Spread to Other Parts of the Body (STAR-221)

first-line treatment of participants with locally advanced unresectable or metastatic gastric, gastroesophageal junction (GEJ), and esophageal adenocarcinoma...

Active, not recruiting
Advanced Upper Gastrointestinal Tract Adenocarcinoma
Drug: Domvanalimab
Drug: Zimberelimab

Phase 3

Arcus Biosciences
Arcus Biosciences

Budapest, Hungary and 207 other locations

Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery (FLORA-5)

Study to compare the safety and efficacy of oregovomab versus placebo, administered in combination with specific cycles of a standard six-cycle chemo...

Active, not recruiting
Fallopian Tube Adenocarcinoma
Fallopian Tube Serous Adenocarcinoma
Drug: Paclitaxel
Biological: Placebo

Phase 3

CanariaBio

Budapest, Hungary and 148 other locations

A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer

T-DXd (Arm A) compared to trastuzumab, chemotherapy, and pembrolizumab (Arm B) in HER2-positive locally advanced or metastatic gastric or GEJ adenocarcinoma...

Enrolling
Gastroesophageal Junction Adenocarcinoma
HER2-positive Gastric Cancer
Drug: Capecitabine
Drug: Trastuzumab deruxtecan

Phase 3

AstraZeneca
AstraZeneca

Budapest, Hungary and 277 other locations

A Study to Evaluate the Safety and the Activity of S095029 as Part of Combination Therapy in Advanced Gastroesophageal Junction/Gastric Cancers.

in in microsatellite instability-high/Defective mismatch repair (MSI-H/dMMR) locally advanced unresectable or metastatic gastric /GEJ adenocarcinomas...

Active, not recruiting
MSI-H/dMMR Gastroesophageal-junction Cancer
MSI-H/dMMR Gastric Cancer
Drug: S095029
Drug: pembrolizumab 200 mg (KEYTRUDA ®)

Phase 1, Phase 2

Servier
Servier

Budapest, Hungary and 48 other locations

Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab for FGFR2b Overexpressed Untreated Advanced Gastric and Gastroesophageal Junction Cancer. (FORTITUDE-102)

The main objective of Part 1 is to evaluate the safety and tolerability of bemarituzumab plus 5-fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6)...

Active, not recruiting
Gastroesophageal Junction Adenocarcinoma
Gastric Cancer
Other: Placebo
Drug: Nivolumab

Phase 3

Amgen
Amgen

Budapest, Hungary and 349 other locations

THIO Sequenced With Cemiplimab in Advanced NSCLC

THIO is a first-in-class small molecule telomere targeting agent, in development for the treatment of non-small cell lung cancer (NSCLC) in combinati...

Enrolling
Carcinoma, Non-Small-Cell Lung
Drug: Cemiplimab
Drug: 6-Thio-2'-Deoxyguanosine

Phase 2

Maia Biotechnology

Budapest, Hungary and 32 other locations

Clinical Trial of YH25448(Lazertinib) as the First-line Treatment in Patients With EGFR Mutation Positive Locally Advanced or Metastatic NSCLC (LASER301)

This Phase III study will be conducted to evaluate the efficacy and safety of YH25448 as first-line treatment in locally advanced or metastatic Non-s...

Active, not recruiting
Non-Small Cell Lung Cancer
Drug: Gefitinib 250 mg
Drug: Gefitinib-matching placebo 250 mg

Phase 3

Yuhan

Törökbálint, Hungary and 79 other locations

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors (SPARTA)

To assess:* efficacy of APL-101 as monotherapy for the treatment of NSCLC harboring MET Exon 14 skipping mutations, NSCLC harboring MET amplification...

Enrolling
Gastroesophageal Junction Adenocarcinoma
Glioblastoma Multiforme
Drug: APL-101 Oral Capsules

Phase 2

Apollomics

Budapest, Hungary and 41 other locations

Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC (CONTACT-02)

This is a Phase 3, multi-center, randomized, open-label, controlled study designed to evaluate the safety and efficacy of cabozantinib given in combi...

Active, not recruiting
Prostate Adenocarcinoma
Metastatic Prostate Cancer
Drug: Cabozantinib
Drug: Abiraterone Acetate

Phase 3

Exelixis
Exelixis

Budapest, Hungary and 279 other locations

Clinical trials

Find clinical trialsTrials by location

Research sites

Find research sitesLearn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy NoticeTerms
© Copyright 2026 Veeva Systems